Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy

Clinical trial NCT04075955 · COMPLETED

Trial details

NCT number: NCT04075955
Sponsor: CR-CSSS Champlain-Charles-Le Moyne
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2019-04-29
Primary completion: 2019-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.